QUANTRX BIOMEDICAL ORD SHS Overview
Valuation check: QTXB's P/E ratio is -0.08.
Get informed when a big investor buys or sells
+ Follow-0.08
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
The latest P/E ratio for QTXB is -0.08. Investors often review this figure alongside QUANTRX BIOMEDICAL ORD SHS's historical trend and sector peers before judging valuation or financial health.
A P/E ratio of -0.08 for QUANTRX BIOMEDICAL ORD SHS is not 'good' or 'bad' on its own. Compare it with the peer average and with QTXB's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting QTXB's P/E ratio (-0.08), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
